Abiomed
ABMD
#1118
Rank
HK$133.57 B
Marketcap
HK$2,962
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Earnings for Abiomed (ABMD)

Earnings in 2022 (TTM): HK$2.67 Billion

According to Abiomed's latest financial reports the company's current earnings are HK$1.07 Billion. In 2021 the company made an earning of HK$1.47 Billion a decrease over its 2020 earnings that were of HK$1.97 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Abiomed from 2013 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) HK$2.67 B81.64%
2021 HK$1.47 B-25.49%
2020 HK$1.97 B-19.62%
2019 HK$2.45 B48.14%
2018 HK$1.65 B51%
2017 HK$1.09 B71.85%
2016 HK$0.63 B41.79%
2015 HK$0.45 B187.69%
2014 HK$0.15 B126.26%
2013 HK$69.25 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$2.74 B 3.44%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$16.66 B 528.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.25 Billion-109.10%๐Ÿ‡บ๐Ÿ‡ธ USA